These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 25389904)

  • 1. Fenofibrate enhances barrier function of endothelial continuum within the metastatic niche of prostate cancer cells.
    Piwowarczyk K; Wybieralska E; Baran J; Borowczyk J; Rybak P; Kosińska M; Włodarczyk AJ; Michalik M; Siedlar M; Madeja Z; Dobrucki J; Reiss K; Czyż J
    Expert Opin Ther Targets; 2015 Feb; 19(2):163-76. PubMed ID: 25389904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fenofibrate attenuates contact-stimulated cell motility and gap junctional coupling in DU-145 human prostate cancer cell populations.
    Wybieralska E; Szpak K; Górecki A; Bonarek P; Miękus K; Drukała J; Majka M; Reiss K; Madeja Z; Czyż J
    Oncol Rep; 2011 Aug; 26(2):447-53. PubMed ID: 21617875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The chemopreventive bioflavonoid apigenin inhibits prostate cancer cell motility through the focal adhesion kinase/Src signaling mechanism.
    Franzen CA; Amargo E; Todorović V; Desai BV; Huda S; Mirzoeva S; Chiu K; Grzybowski BA; Chew TL; Green KJ; Pelling JC
    Cancer Prev Res (Phila); 2009 Sep; 2(9):830-41. PubMed ID: 19737984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fenofibrate inhibits endothelin-1 expression by peroxisome proliferator-activated receptor α-dependent and independent mechanisms in human endothelial cells.
    Glineur C; Gross B; Neve B; Rommens C; Chew GT; Martin-Nizard F; Rodríguez-Pascual F; Lamas S; Watts GF; Staels B
    Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):621-8. PubMed ID: 23329136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fenofibrate Interferes with the Diapedesis of Lung Adenocarcinoma Cells through the Interference with Cx43/EGF-Dependent Intercellular Signaling.
    Piwowarczyk K; Kwiecień E; Sośniak J; Zimoląg E; Guzik E; Sroka J; Madeja Z; Czyż J
    Cancers (Basel); 2018 Sep; 10(10):. PubMed ID: 30274176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PPARalpha agonist fenofibrate suppresses tumor growth through direct and indirect angiogenesis inhibition.
    Panigrahy D; Kaipainen A; Huang S; Butterfield CE; Barnés CM; Fannon M; Laforme AM; Chaponis DM; Folkman J; Kieran MW
    Proc Natl Acad Sci U S A; 2008 Jan; 105(3):985-90. PubMed ID: 18199835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shikonin inhibits prostate cancer cells metastasis by reducing matrix metalloproteinase-2/-9 expression via AKT/mTOR and ROS/ERK1/2 pathways.
    Chen Y; Zheng L; Liu J; Zhou Z; Cao X; Lv X; Chen F
    Int Immunopharmacol; 2014 Aug; 21(2):447-55. PubMed ID: 24905636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fenofibrate suppresses growth of the human hepatocellular carcinoma cell via PPARα-independent mechanisms.
    Yamasaki D; Kawabe N; Nakamura H; Tachibana K; Ishimoto K; Tanaka T; Aburatani H; Sakai J; Hamakubo T; Kodama T; Doi T
    Eur J Cell Biol; 2011 Aug; 90(8):657-64. PubMed ID: 21514001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptor alpha activation decreases metastatic potential of melanoma cells in vitro via down-regulation of Akt.
    Grabacka M; Plonka PM; Urbanska K; Reiss K
    Clin Cancer Res; 2006 May; 12(10):3028-36. PubMed ID: 16707598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell surface heat shock protein 90 modulates prostate cancer cell adhesion and invasion through the integrin-β1/focal adhesion kinase/c-Src signaling pathway.
    Liu X; Yan Z; Huang L; Guo M; Zhang Z; Guo C
    Oncol Rep; 2011 May; 25(5):1343-51. PubMed ID: 21369706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of PPARalpha-dependent and PPARalpha-independent transcript regulation following fenofibrate treatment of human endothelial cells.
    Araki H; Tamada Y; Imoto S; Dunmore B; Sanders D; Humphrey S; Nagasaki M; Doi A; Nakanishi Y; Yasuda K; Tomiyasu Y; Tashiro K; Print C; Charnock-Jones DS; Kuhara S; Miyano S
    Angiogenesis; 2009; 12(3):221-9. PubMed ID: 19357976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactive oxygen species increased focal adhesion kinase production in pulmonary microvascular endothelial cells.
    Yang S; Yip R; Polena S; Sharma M; Rao S; Griciene P; Gintautas J; Jerome H
    Proc West Pharmacol Soc; 2004; 47():54-6. PubMed ID: 15633612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fenofibrate down-regulates the expressions of androgen receptor (AR) and AR target genes and induces oxidative stress in the prostate cancer cell line LNCaP.
    Zhao H; Zhu C; Qin C; Tao T; Li J; Cheng G; Li P; Cao Q; Meng X; Ju X; Shao P; Hua L; Gu M; Yin C
    Biochem Biophys Res Commun; 2013 Mar; 432(2):320-5. PubMed ID: 23399562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of focal adhesion kinase and phosphatidylinositol 3'-kinase in integrin fibronectin receptor-mediated, matrix metalloproteinase-1-dependent invasion by metastatic prostate cancer cells.
    Zeng ZZ; Jia Y; Hahn NJ; Markwart SM; Rockwood KF; Livant DL
    Cancer Res; 2006 Aug; 66(16):8091-9. PubMed ID: 16912186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific amino acid dependency regulates invasiveness and viability of androgen-independent prostate cancer cells.
    Fu YM; Yu ZX; Li YQ; Ge X; Sanchez PJ; Fu X; Meadows GG
    Nutr Cancer; 2003; 45(1):60-73. PubMed ID: 12791506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progesterone receptor enhances breast cancer cell motility and invasion via extranuclear activation of focal adhesion kinase.
    Fu XD; Goglia L; Sanchez AM; Flamini M; Giretti MS; Tosi V; Genazzani AR; Simoncini T
    Endocr Relat Cancer; 2010 Jun; 17(2):431-43. PubMed ID: 20233709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low dosed interferon alpha augments the anti-tumor potential of histone deacetylase inhibition on prostate cancer cell growth and invasion.
    Hudak L; Tezeeh P; Wedel S; Makarević J; Juengel E; Tsaur I; Bartsch G; Wiesner C; Haferkamp A; Blaheta RA
    Prostate; 2012 Dec; 72(16):1719-35. PubMed ID: 22473339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ROS accumulation and IGF-IR inhibition contribute to fenofibrate/PPARalpha -mediated inhibition of glioma cell motility in vitro.
    Drukala J; Urbanska K; Wilk A; Grabacka M; Wybieralska E; Del Valle L; Madeja Z; Reiss K
    Mol Cancer; 2010 Jun; 9():159. PubMed ID: 20569465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maslinic acid inhibits the metastatic capacity of DU145 human prostate cancer cells: possible mediation via hypoxia-inducible factor-1α signalling.
    Park SY; Nho CW; Kwon DY; Kang YH; Lee KW; Park JH
    Br J Nutr; 2013 Jan; 109(2):210-22. PubMed ID: 22716951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Focal adhesion kinase is required for bombesin-induced prostate cancer cell motility.
    Lacoste J; Aprikian AG; Chevalier S
    Mol Cell Endocrinol; 2005 May; 235(1-2):51-61. PubMed ID: 15866427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.